HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea
· Delayed Price · Currency is KRW 1,781.00
-51.00 (-2.78%)
At close: Mar 28, 2025, 3:30 PM KST
HLB bioStep Revenue
In the year 2024, HLB bioStep had annual revenue of 58.17B KRW with 10.14% growth. HLB bioStep had revenue of 16.14B in the quarter ending December 31, 2024, with 9.60% growth.
Revenue
58.17B
Revenue Growth
+10.14%
P/S Ratio
2.55
Revenue / Employee
387.79M
Employees
150
Market Cap
145.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.17B | 5.35B | 10.14% |
| Dec 31, 2023 | 52.81B | -33.46B | -38.79% |
| Dec 31, 2022 | 86.28B | 21.87B | 33.96% |
| Dec 31, 2021 | 64.40B | 5.88B | 10.05% |
| Dec 31, 2020 | 58.52B | 12.48B | 27.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |